Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy

Administration of autologous mesenchymal stem cells (MSCs) has been shown to improve renal function and histological findings in acute kidney injury (AKI) models. However, its effects in chronic kidney disease (CKD) are unclear, particularly in the clinical setting. Here, we report our experience wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jun-Seop, Lee, Jong-Hak, Kwon, Owen, Cho, Jang-Hee, Choi, Ji-Young, Park, Sun-Hee, Kim, Chan-Duck, Kim, Yong-Jin, Kim, Yong-Lim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Nephrology 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491167/
https://www.ncbi.nlm.nih.gov/pubmed/28680828
http://dx.doi.org/10.23876/j.krcp.2017.36.2.200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491167/
https://www.ncbi.nlm.nih.gov/pubmed/28680828
http://dx.doi.org/10.23876/j.krcp.2017.36.2.200

Ejemplares similares